Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.

Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully ...

Key Takeaways Roche announced plans to acquire Poseida Therapeutics for about $1 billion. Merck, AstraZeneca and Novartis ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Biotech giant Gilead Sciences, Inc.’s GILD shares have risen 44.2% in the past six months compared with the industry’s growth of 1.1%. The stock has also outperformed the sector and the S&P 500. It ...